Brunei Darussalam vs Oman: The number of people with susceptibility test result for rifampicin
Brunei Darussalam
162
in 2021
Oman
144
in 2021
Brunei Darussalam rank
99th
Oman rank
102nd
The number of people with susceptibility test result for rifampicin over time
- Brunei Darussalam
- Oman
How they compare
Brunei Darussalam currently reports 162 against 144 in Oman, a difference of 18.
That makes Brunei Darussalam's figure about 1.1 times Oman's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Oman ahead.
Brunei Darussalam ranks 99th and Oman ranks 102nd of 155 countries.
Across the 2 decades both report, Brunei Darussalam averaged higher in 1 and Oman in 1.
Head to head by decade
| Decade | Brunei Darussalam | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 187 | 220.67 | 33.67 | Oman |
| 2020s | 195.5 | 181 | 14.5 | Brunei Darussalam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Brunei Darussalam or Oman?
- Brunei Darussalam, at 162 against 144 in Oman as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Brunei Darussalam and Oman?
- 18, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Oman?
- 5 years are reported by both, from 2017 to 2021.
- How do Brunei Darussalam and Oman rank globally for the number of people with susceptibility test result for rifampicin?
- Brunei Darussalam ranks 99th and Oman ranks 102nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.